FDA recall D-0202-2025

Product

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Reason for recall

Failed Dissolution Specifications:

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2024-12-17

Report date

2025-01-22

Termination date

2026-04-16

Voluntary/Mandated

Voluntary: Firm initiated

Location

Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0202-2025